- Details
- Written by IVN
- Category: Latest News
Washington, DC - In an Initial Decision announced on May 18, 2018, Chief Administrative Law Judge D. Michael Chappell dismissed the antitrust charges in a complaint issued by the Federal Trade Commission against generic pharmaceutical company Impax Laboratories, Inc.
- Details
- Written by White House
- Category: Latest News
Washington, DC - Streamlining Regulations on Commercial Use of Space:
- Details
- Written by State Department
- Category: Latest News
Washington, DC - Full Committee Hearing Review of the FY 2019 State Department Budget Request:
- Details
- Written by Sandy Walsh
- Category: Latest News
Washington, DC - The U.S. Food and Drug Administration is warning consumers that over-the-counter (OTC) teething products containing benzocaine pose a serious risk to infants and children. The agency today announced that OTC oral health products containing the pain reliever benzocaine for the temporary relief of sore gums due to teething in infants or children should no longer be marketed and is asking companies to stop selling these products for such use. If companies do not comply, the FDA will initiate a regulatory action to remove these products from the market. Also, the agency is requesting that companies add new warnings to all other benzocaine oral health products to describe certain serious risks.
- Details
- Written by IVN
- Category: Latest News
Washington, DC - The Federal Trade Commission has charged a Florida-based scheme with deceiving small business owners by falsely claiming to represent Google, falsely threatening businesses with removal from Google search results, and falsely promising first-place or first-page placement in Google search results.
- Details
- Written by White House
- Category: Latest News
Washington, DC - "This time, we will not only plant our flag and leave our footprint. We will establish a foundation for an eventual mission to Mars." ~ President Donald J. Trump
Page 81 of 517
